hVIVO plc

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, NONOF has a market cap of 160.2B. Regarding current trading prices, OPORF is priced at $0.09, while NONOF trades at $35.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas NONOF's P/E ratio is 10.13. In terms of profitability, OPORF's ROE is +0.12%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, OPORF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check NONOF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CSLLY has a market cap of 95.3B. Regarding current trading prices, OPORF is priced at $0.09, while CSLLY trades at $24.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CSLLY's P/E ratio is 15.98. In terms of profitability, OPORF's ROE is +0.12%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, OPORF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check CSLLY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, UCBJF has a market cap of 57B. Regarding current trading prices, OPORF is priced at $0.09, while UCBJF trades at $299.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas UCBJF's P/E ratio is 32.29. In terms of profitability, OPORF's ROE is +0.12%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, OPORF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check UCBJF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, UCBJY has a market cap of 55.7B. Regarding current trading prices, OPORF is priced at $0.09, while UCBJY trades at $145.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas UCBJY's P/E ratio is 31.51. In terms of profitability, OPORF's ROE is +0.12%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, OPORF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check UCBJY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ARGNF has a market cap of 50.4B. Regarding current trading prices, OPORF is priced at $0.09, while ARGNF trades at $814.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ARGNF's P/E ratio is 41.66. In terms of profitability, OPORF's ROE is +0.12%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, OPORF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ARGNF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CMXHF has a market cap of 47.9B. Regarding current trading prices, OPORF is priced at $0.09, while CMXHF trades at $99.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CMXHF's P/E ratio is 16.00. In terms of profitability, OPORF's ROE is +0.12%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, OPORF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check CMXHF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, WXIBF has a market cap of 19B. Regarding current trading prices, OPORF is priced at $0.09, while WXIBF trades at $4.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas WXIBF's P/E ratio is 32.86. In terms of profitability, OPORF's ROE is +0.12%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, OPORF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check WXIBF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, WXXWY has a market cap of 17.4B. Regarding current trading prices, OPORF is priced at $0.09, while WXXWY trades at $8.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas WXXWY's P/E ratio is 30.11. In terms of profitability, OPORF's ROE is +0.12%, compared to WXXWY's ROE of +0.10%. Regarding short-term risk, OPORF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check WXXWY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, IVBXF has a market cap of 16.8B. Regarding current trading prices, OPORF is priced at $0.09, while IVBXF trades at $9.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas IVBXF's P/E ratio is 97.50. In terms of profitability, OPORF's ROE is +0.12%, compared to IVBXF's ROE of +0.08%. Regarding short-term risk, OPORF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check IVBXF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, GNMSF has a market cap of 16.5B. Regarding current trading prices, OPORF is priced at $0.09, while GNMSF trades at $267.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas GNMSF's P/E ratio is 17.40. In terms of profitability, OPORF's ROE is +0.12%, compared to GNMSF's ROE of +0.14%. Regarding short-term risk, OPORF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check GNMSF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, SBMFF has a market cap of 14.8B. Regarding current trading prices, OPORF is priced at $0.09, while SBMFF trades at $0.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas SBMFF's P/E ratio is 27.67. In terms of profitability, OPORF's ROE is +0.12%, compared to SBMFF's ROE of +0.12%. Regarding short-term risk, OPORF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check SBMFF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, OPORF is priced at $0.09, while SBHMY trades at $15.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas SBHMY's P/E ratio is 25.22. In terms of profitability, OPORF's ROE is +0.12%, compared to SBHMY's ROE of +0.12%. Regarding short-term risk, OPORF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check SBHMY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, OPORF is priced at $0.09, while BRRGF trades at $97.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, OPORF's ROE is +0.12%, compared to BRRGF's ROE of -1.05%. Regarding short-term risk, OPORF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for OPORF.Check BRRGF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, OPORF is priced at $0.09, while AAVXF trades at $115.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, OPORF's ROE is +0.12%, compared to AAVXF's ROE of +50.78%. Regarding short-term risk, OPORF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check AAVXF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, OPORF is priced at $0.09, while ODTC trades at $22,005.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ODTC's P/E ratio is 1.07. In terms of profitability, OPORF's ROE is +0.12%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, OPORF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ODTC's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, AKBLF has a market cap of 6.5B. Regarding current trading prices, OPORF is priced at $0.09, while AKBLF trades at $32.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas AKBLF's P/E ratio is 38.30. In terms of profitability, OPORF's ROE is +0.12%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, OPORF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check AKBLF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, TRSBF has a market cap of 6.1B. Regarding current trading prices, OPORF is priced at $0.09, while TRSBF trades at $2.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas TRSBF's P/E ratio is 18.43. In terms of profitability, OPORF's ROE is +0.12%, compared to TRSBF's ROE of +0.15%. Regarding short-term risk, OPORF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check TRSBF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, REGMF has a market cap of 5.6B. Regarding current trading prices, OPORF is priced at $0.09, while REGMF trades at $10.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas REGMF's P/E ratio is -32.26. In terms of profitability, OPORF's ROE is +0.12%, compared to REGMF's ROE of +0.33%. Regarding short-term risk, OPORF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check REGMF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, OPORF is priced at $0.09, while ABCZF trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, OPORF's ROE is +0.12%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, OPORF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ABCZF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, OPORF is priced at $0.09, while LABFF trades at $90.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas LABFF's P/E ratio is 28.95. In terms of profitability, OPORF's ROE is +0.12%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, OPORF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check LABFF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, OPORF is priced at $0.09, while SHJBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, OPORF's ROE is +0.12%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, OPORF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check SHJBF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, OPORF is priced at $0.09, while CAMRF trades at $55.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CAMRF's P/E ratio is 42.31. In terms of profitability, OPORF's ROE is +0.12%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, OPORF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check CAMRF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, OPORF is priced at $0.09, while ASPHF trades at $8.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, OPORF's ROE is +0.12%, compared to ASPHF's ROE of -1.40%. Regarding short-term risk, OPORF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ASPHF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ZLDPF has a market cap of 3.1B. Regarding current trading prices, OPORF is priced at $0.09, while ZLDPF trades at $44.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ZLDPF's P/E ratio is 3.18. In terms of profitability, OPORF's ROE is +0.12%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, OPORF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ZLDPF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, OPORF is priced at $0.09, while GNNSF trades at $1.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas GNNSF's P/E ratio is -5.68. In terms of profitability, OPORF's ROE is +0.12%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, OPORF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check GNNSF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, TLPPF has a market cap of 3B. Regarding current trading prices, OPORF is priced at $0.09, while TLPPF trades at $8.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas TLPPF's P/E ratio is -446.50. In terms of profitability, OPORF's ROE is +0.12%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, OPORF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check TLPPF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, OPORF is priced at $0.09, while BRCTF trades at $33.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas BRCTF's P/E ratio is 26.85. In terms of profitability, OPORF's ROE is +0.12%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, OPORF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check BRCTF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, OPORF is priced at $0.09, while MPSYF trades at $73.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, OPORF's ROE is +0.12%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, OPORF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check MPSYF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, GENSF has a market cap of 2.4B. Regarding current trading prices, OPORF is priced at $0.09, while GENSF trades at $35.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas GENSF's P/E ratio is 37.86. In terms of profitability, OPORF's ROE is +0.12%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, OPORF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check GENSF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, OPORF is priced at $0.09, while INCPF trades at $1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas INCPF's P/E ratio is -77.50. In terms of profitability, OPORF's ROE is +0.12%, compared to INCPF's ROE of -0.03%. Regarding short-term risk, OPORF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check INCPF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, OPORF is priced at $0.09, while BVNRY trades at $9.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas BVNRY's P/E ratio is 10.66. In terms of profitability, OPORF's ROE is +0.12%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, OPORF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check BVNRY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, BVNKF has a market cap of 2.2B. Regarding current trading prices, OPORF is priced at $0.09, while BVNKF trades at $28.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas BVNKF's P/E ratio is 10.33. In terms of profitability, OPORF's ROE is +0.12%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, OPORF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check BVNKF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, OPORF is priced at $0.09, while GLPGF trades at $33.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas GLPGF's P/E ratio is -4.15. In terms of profitability, OPORF's ROE is +0.12%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, OPORF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check GLPGF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, MEOBF has a market cap of 2B. Regarding current trading prices, OPORF is priced at $0.09, while MEOBF trades at $1.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas MEOBF's P/E ratio is -15.90. In terms of profitability, OPORF's ROE is +0.12%, compared to MEOBF's ROE of -0.18%. Regarding short-term risk, OPORF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check MEOBF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ASCLF has a market cap of 1.9B. Regarding current trading prices, OPORF is priced at $0.09, while ASCLF trades at $1.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ASCLF's P/E ratio is -45.25. In terms of profitability, OPORF's ROE is +0.12%, compared to ASCLF's ROE of -0.13%. Regarding short-term risk, OPORF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ASCLF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, OPORF is priced at $0.09, while ONTTF trades at $1.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ONTTF's P/E ratio is -8.65. In terms of profitability, OPORF's ROE is +0.12%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, OPORF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ONTTF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, OPORF is priced at $0.09, while BIESF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas BIESF's P/E ratio is -44.44. In terms of profitability, OPORF's ROE is +0.12%, compared to BIESF's ROE of -0.07%. Regarding short-term risk, OPORF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check BIESF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, OPORF is priced at $0.09, while PHMMF trades at $92.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas PHMMF's P/E ratio is 40.08. In terms of profitability, OPORF's ROE is +0.12%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, OPORF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check PHMMF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, OPORF is priced at $0.09, while HBMHF trades at $1.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, OPORF's ROE is +0.12%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, OPORF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check HBMHF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, OPORF is priced at $0.09, while SNBIF trades at $16.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, OPORF's ROE is +0.12%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, OPORF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for OPORF.Check SNBIF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CSPHF has a market cap of 1.2B. Regarding current trading prices, OPORF is priced at $0.09, while CSPHF trades at $0.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CSPHF's P/E ratio is -21.25. In terms of profitability, OPORF's ROE is +0.12%, compared to CSPHF's ROE of -0.71%. Regarding short-term risk, OPORF is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check CSPHF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, OPORF is priced at $0.09, while MDCLF trades at $34.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, OPORF's ROE is +0.12%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, OPORF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check MDCLF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, OPORF is priced at $0.09, while CSBTF trades at $28.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CSBTF's P/E ratio is 362.50. In terms of profitability, OPORF's ROE is +0.12%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, OPORF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check CSBTF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, PHGUF has a market cap of 1.1B. Regarding current trading prices, OPORF is priced at $0.09, while PHGUF trades at $1.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas PHGUF's P/E ratio is -151.00. In terms of profitability, OPORF's ROE is +0.12%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, OPORF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check PHGUF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, OPORF is priced at $0.09, while NURPF trades at $8.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas NURPF's P/E ratio is 51.38. In terms of profitability, OPORF's ROE is +0.12%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, OPORF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check NURPF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, IDRSF has a market cap of 1B. Regarding current trading prices, OPORF is priced at $0.09, while IDRSF trades at $4.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas IDRSF's P/E ratio is -6.11. In terms of profitability, OPORF's ROE is +0.12%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, OPORF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check IDRSF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, PPTDF has a market cap of 1B. Regarding current trading prices, OPORF is priced at $0.09, while PPTDF trades at $7.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas PPTDF's P/E ratio is -43.06. In terms of profitability, OPORF's ROE is +0.12%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, OPORF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check PPTDF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, OPORF is priced at $0.09, while BTTAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, OPORF's ROE is +0.12%, compared to BTTAY's ROE of -0.07%. Regarding short-term risk, OPORF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check BTTAY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, OPORF is priced at $0.09, while TKBIF trades at $7.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, OPORF's ROE is +0.12%, compared to TKBIF's ROE of N/A. Regarding short-term risk, OPORF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check TKBIF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, BPMUF has a market cap of 871.3M. Regarding current trading prices, OPORF is priced at $0.09, while BPMUF trades at $71.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, OPORF's ROE is +0.12%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, OPORF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check BPMUF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, OPORF is priced at $0.09, while VBIZF trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, OPORF's ROE is +0.12%, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, OPORF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check VBIZF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, IVEVF has a market cap of 617.4M. Regarding current trading prices, OPORF is priced at $0.09, while IVEVF trades at $4.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas IVEVF's P/E ratio is -1.00. In terms of profitability, OPORF's ROE is +0.12%, compared to IVEVF's ROE of +5.38%. Regarding short-term risk, OPORF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check IVEVF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, INRLF has a market cap of 602.3M. Regarding current trading prices, OPORF is priced at $0.09, while INRLF trades at $3.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas INRLF's P/E ratio is -4.43. In terms of profitability, OPORF's ROE is +0.12%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, OPORF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check INRLF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, OPORF is priced at $0.09, while CKDXF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, OPORF's ROE is +0.12%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, OPORF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check CKDXF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, GNFTF has a market cap of 521.9M. Regarding current trading prices, OPORF is priced at $0.09, while GNFTF trades at $10.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas GNFTF's P/E ratio is -11.59. In terms of profitability, OPORF's ROE is +0.12%, compared to GNFTF's ROE of -0.64%. Regarding short-term risk, OPORF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check GNFTF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, SOLTF has a market cap of 477.8M. Regarding current trading prices, OPORF is priced at $0.09, while SOLTF trades at $5.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas SOLTF's P/E ratio is -6.07. In terms of profitability, OPORF's ROE is +0.12%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, OPORF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check SOLTF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, OPORF is priced at $0.09, while RAONF trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas RAONF's P/E ratio is -43.33. In terms of profitability, OPORF's ROE is +0.12%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, OPORF is more volatile compared to RAONF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check RAONF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, OPORF is priced at $0.09, while GNFTY trades at $8.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, OPORF's ROE is +0.12%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, OPORF is more volatile compared to GNFTY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check GNFTY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, OPORF is priced at $0.09, while TBGNF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, OPORF's ROE is +0.12%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, OPORF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check TBGNF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, OPORF is priced at $0.09, while CLVLF trades at $8.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, OPORF's ROE is +0.12%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, OPORF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check CLVLF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, AVCTF has a market cap of 400.3M. Regarding current trading prices, OPORF is priced at $0.09, while AVCTF trades at $0.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas AVCTF's P/E ratio is -6.10. In terms of profitability, OPORF's ROE is +0.12%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, OPORF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check AVCTF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, PTCHF has a market cap of 374.8M. Regarding current trading prices, OPORF is priced at $0.09, while PTCHF trades at $1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas PTCHF's P/E ratio is 9.12. In terms of profitability, OPORF's ROE is +0.12%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, OPORF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check PTCHF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CLVLY has a market cap of 343.4M. Regarding current trading prices, OPORF is priced at $0.09, while CLVLY trades at $7.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CLVLY's P/E ratio is 15.20. In terms of profitability, OPORF's ROE is +0.12%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, OPORF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check CLVLY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, NWBO has a market cap of 330.5M. Regarding current trading prices, OPORF is priced at $0.09, while NWBO trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas NWBO's P/E ratio is -3.57. In terms of profitability, OPORF's ROE is +0.12%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, OPORF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check NWBO's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CYDY has a market cap of 327.9M. Regarding current trading prices, OPORF is priced at $0.09, while CYDY trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CYDY's P/E ratio is -8.60. In terms of profitability, OPORF's ROE is +0.12%, compared to CYDY's ROE of +0.38%. Regarding short-term risk, OPORF is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check CYDY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CMVLF has a market cap of 325.5M. Regarding current trading prices, OPORF is priced at $0.09, while CMVLF trades at $4.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CMVLF's P/E ratio is -6.72. In terms of profitability, OPORF's ROE is +0.12%, compared to CMVLF's ROE of -0.72%. Regarding short-term risk, OPORF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check CMVLF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, OPORF is priced at $0.09, while NGENF trades at $3.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas NGENF's P/E ratio is -15.19. In terms of profitability, OPORF's ROE is +0.12%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, OPORF is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check NGENF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, HLOSF has a market cap of 312.5M. Regarding current trading prices, OPORF is priced at $0.09, while HLOSF trades at $2.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas HLOSF's P/E ratio is -9.00. In terms of profitability, OPORF's ROE is +0.12%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, OPORF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check HLOSF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, OPORF is priced at $0.09, while FGHQF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, OPORF's ROE is +0.12%, compared to FGHQF's ROE of +0.01%. Regarding short-term risk, OPORF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check FGHQF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, OPORF is priced at $0.09, while PBBIF trades at $24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, OPORF's ROE is +0.12%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, OPORF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check PBBIF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, SLNCF has a market cap of 283.4M. Regarding current trading prices, OPORF is priced at $0.09, while SLNCF trades at $2.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas SLNCF's P/E ratio is -3.17. In terms of profitability, OPORF's ROE is +0.12%, compared to SLNCF's ROE of -4.29%. Regarding short-term risk, OPORF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check SLNCF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, SPHDF has a market cap of 273.5M. Regarding current trading prices, OPORF is priced at $0.09, while SPHDF trades at $19.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas SPHDF's P/E ratio is -2.85. In terms of profitability, OPORF's ROE is +0.12%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, OPORF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check SPHDF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ORYZF has a market cap of 263.4M. Regarding current trading prices, OPORF is priced at $0.09, while ORYZF trades at $3.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, OPORF's ROE is +0.12%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, OPORF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ORYZF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, OPORF is priced at $0.09, while ORPOF trades at $11.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, OPORF's ROE is +0.12%, compared to ORPOF's ROE of N/A. Regarding short-term risk, OPORF is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ORPOF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, OPORF is priced at $0.09, while HNSBF trades at $2.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas HNSBF's P/E ratio is -4.14. In terms of profitability, OPORF's ROE is +0.12%, compared to HNSBF's ROE of +1.24%. Regarding short-term risk, OPORF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check HNSBF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, NWPHF has a market cap of 239.5M. Regarding current trading prices, OPORF is priced at $0.09, while NWPHF trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas NWPHF's P/E ratio is N/A. In terms of profitability, OPORF's ROE is +0.12%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, OPORF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check NWPHF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, OPORF is priced at $0.09, while CAIHF trades at $0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, OPORF's ROE is +0.12%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, OPORF is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for OPORF.Check CAIHF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, OPORF is priced at $0.09, while BOVNF trades at $3.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, OPORF's ROE is +0.12%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, OPORF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check BOVNF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, OPORF is priced at $0.09, while FPHAF trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, OPORF's ROE is +0.12%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, OPORF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check FPHAF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, KNTPF has a market cap of 202.9M. Regarding current trading prices, OPORF is priced at $0.09, while KNTPF trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas KNTPF's P/E ratio is -7.21. In terms of profitability, OPORF's ROE is +0.12%, compared to KNTPF's ROE of -0.35%. Regarding short-term risk, OPORF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check KNTPF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, MLLCF has a market cap of 185.5M. Regarding current trading prices, OPORF is priced at $0.09, while MLLCF trades at $4.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas MLLCF's P/E ratio is -2.37. In terms of profitability, OPORF's ROE is +0.12%, compared to MLLCF's ROE of -0.60%. Regarding short-term risk, OPORF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check MLLCF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, OPORF is priced at $0.09, while ADOCY trades at $11.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, OPORF's ROE is +0.12%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, OPORF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ADOCY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, SCNLF has a market cap of 162.7M. Regarding current trading prices, OPORF is priced at $0.09, while SCNLF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas SCNLF's P/E ratio is -15.68. In terms of profitability, OPORF's ROE is +0.12%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, OPORF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check SCNLF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, BBIXF has a market cap of 140.2M. Regarding current trading prices, OPORF is priced at $0.09, while BBIXF trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas BBIXF's P/E ratio is -12.00. In terms of profitability, OPORF's ROE is +0.12%, compared to BBIXF's ROE of -8.24%. Regarding short-term risk, OPORF is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for OPORF.Check BBIXF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, AMGXF has a market cap of 139.1M. Regarding current trading prices, OPORF is priced at $0.09, while AMGXF trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, OPORF's ROE is +0.12%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, OPORF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check AMGXF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, SPHRF has a market cap of 138.6M. Regarding current trading prices, OPORF is priced at $0.09, while SPHRF trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas SPHRF's P/E ratio is -33.00. In terms of profitability, OPORF's ROE is +0.12%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, OPORF is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check SPHRF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, SPHRY has a market cap of 136.5M. Regarding current trading prices, OPORF is priced at $0.09, while SPHRY trades at $3.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas SPHRY's P/E ratio is -54.17. In terms of profitability, OPORF's ROE is +0.12%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, OPORF is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check SPHRY's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, OPORF is priced at $0.09, while BRIBF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, OPORF's ROE is +0.12%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, OPORF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check BRIBF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, OPORF is priced at $0.09, while HBPCF trades at $1.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas HBPCF's P/E ratio is -34.60. In terms of profitability, OPORF's ROE is +0.12%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, OPORF is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check HBPCF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, TRGNF has a market cap of 132.1M. Regarding current trading prices, OPORF is priced at $0.09, while TRGNF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, OPORF's ROE is +0.12%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, OPORF is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check TRGNF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, IPHYF has a market cap of 128.7M. Regarding current trading prices, OPORF is priced at $0.09, while IPHYF trades at $1.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas IPHYF's P/E ratio is -2.11. In terms of profitability, OPORF's ROE is +0.12%, compared to IPHYF's ROE of -6.59%. Regarding short-term risk, OPORF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check IPHYF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, JWCTF has a market cap of 127.5M. Regarding current trading prices, OPORF is priced at $0.09, while JWCTF trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, OPORF's ROE is +0.12%, compared to JWCTF's ROE of -0.59%. Regarding short-term risk, OPORF is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check JWCTF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, OPORF is priced at $0.09, while AAPGV trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas AAPGV's P/E ratio is N/A. In terms of profitability, OPORF's ROE is +0.12%, compared to AAPGV's ROE of -2.49%. Regarding short-term risk, OPORF is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check AAPGV's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, OPORF is priced at $0.09, while PSTTF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, OPORF's ROE is +0.12%, compared to PSTTF's ROE of N/A. Regarding short-term risk, OPORF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check PSTTF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, NDTP has a market cap of 116.8M. Regarding current trading prices, OPORF is priced at $0.09, while NDTP trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas NDTP's P/E ratio is -2.52. In terms of profitability, OPORF's ROE is +0.12%, compared to NDTP's ROE of -0.24%. Regarding short-term risk, OPORF is more volatile compared to NDTP. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check NDTP's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ATGGF has a market cap of 111.2M. Regarding current trading prices, OPORF is priced at $0.09, while ATGGF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ATGGF's P/E ratio is N/A. In terms of profitability, OPORF's ROE is +0.12%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, OPORF is more volatile compared to ATGGF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ATGGF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, MSCLF has a market cap of 109.4M. Regarding current trading prices, OPORF is priced at $0.09, while MSCLF trades at $7.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas MSCLF's P/E ratio is 2.75. In terms of profitability, OPORF's ROE is +0.12%, compared to MSCLF's ROE of -0.52%. Regarding short-term risk, OPORF is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check MSCLF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, OPORF is priced at $0.09, while EPRXF trades at $3.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, OPORF's ROE is +0.12%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, OPORF is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check EPRXF's competition here

OPORF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPORF stands at 59.3M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, OPORF is priced at $0.09, while ADOIF trades at $8.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPORF currently has a P/E ratio of 8.61, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, OPORF's ROE is +0.12%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, OPORF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for OPORF.Check ADOIF's competition here